Sabater E, Rueda A, Salar A, López-Guillermo A, Oyagüez I, Collar JM Cost-effectiveness analysis of bendamustine plus rituximab as first-line treatment for patients with folicular lymphoma. Preliminary results 19th Congress of European Hematology Association (EHA). Milan, Italia. 12-15 jun 2014 POSTER
Sabater E, Rueda A, Salar A, López-Guillermo A, Oyagüez I, Collar JMSabater E, Rueda A, Salar A, López-Guillermo A, Oyagüez I, Collar JM